CT Biphasic with Contrast Scan at Lahore PCR Lab

CT Biphasic with Contrast at Lahore PCR Lab

A CT Biphasic with Contrast scan is a highly specialized, advanced diagnostic imaging modality designed to evaluate the vascularity of internal organs, with a primary focus on the liver, pancreas, and kidneys. Unlike standard computed tomography (CT) scans that capture images at a single point in time, a biphasic study acquires high-resolution cross-sectional images during two distinct phases of contrast enhancement: the late arterial phase and the portal venous phase. This precise timing allows consultant radiologists at Lahore PCR Lab to observe how blood flows through tissues and lesions, providing invaluable diagnostic insights that are critical for accurate clinical decision-making.

The technology behind this examination relies on multi-detector computed tomography (MDCT) scanners. These modern scanners utilize a rotating X-ray tube and a curved array of highly sensitive detectors to acquire multiple slices of the body simultaneously. When combined with an automated power injector that delivers a precise volume of iodinated contrast medium into the patient’s venous system, the scanner can capture rapid, sequential images at exact millisecond intervals. This dual-phase acquisition is essential because different anatomical structures and pathological lesions receive their blood supply from different vascular systems. For instance, normal liver tissue receives approximately 75% of its blood supply from the portal vein and only 25% from the hepatic artery, whereas primary liver tumors, such as hepatocellular carcinoma (HCC), derive nearly 100% of their blood supply from the hepatic artery. By capturing images during both the arterial and portal venous phases, clinicians can easily differentiate between benign and malignant lesions based on their unique enhancement patterns.

The clinical importance of a CT Biphasic with Contrast scan cannot be overstated. It serves as a cornerstone in oncological imaging, particularly for staging abdominal malignancies, planning complex surgical resections, and monitoring the efficacy of therapies such as transarterial chemoembolization (TACE) or systemic chemotherapy. The diagnostic value lies in its ability to characterize lesions that might otherwise remain indeterminate on a standard single-phase CT scan. By choosing Lahore PCR Lab in Lahore, Pakistan, patients benefit from a meticulous imaging protocol designed to maximize diagnostic accuracy while adhering to international safety standards.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure the safety of the procedure and the clarity of the resulting images. Patients scheduled for a CT Biphasic with Contrast at Lahore PCR Lab must adhere to the following guidelines:

• Fasting Requirements: Patients are required to fast (no solid food or liquids other than water) for at least 4 to 6 hours prior to the scan. This minimizes the risk of nausea or vomiting, which can occasionally occur during the rapid injection of iodinated contrast media.
• Renal Function Assessment: Because the iodinated contrast agent is cleared from the body through the kidneys, patients must present a recent serum creatinine and estimated Glomerular Filtration Rate (eGFR) report. This is especially critical for patients over 60 years of age, or those with a history of diabetes, hypertension, or renal disease.
• Hydration Protocol: Patients are encouraged to drink plenty of water before and after the scan. Adequate hydration helps protect the kidneys and facilitates the rapid excretion of the contrast agent post-procedure.
• Allergy History: It is imperative to inform the clinical staff of any known allergies, particularly to iodine, contrast media, or shellfish. Patients with a history of severe allergies or asthma may require a pre-medication regimen consisting of oral corticosteroids and antihistamines, which must be started the day before the scan.
• Medication Management: Patients taking Metformin for diabetes must consult their prescribing physician. Metformin may need to be temporarily discontinued on the day of the scan and withheld for 48 hours afterward to prevent the rare risk of lactic acidosis, subject to normal post-scan renal function.
• Appropriate Attire: Patients should wear comfortable, loose-fitting clothing. All metallic objects, including jewelry, belts, piercings, and clothing with metal zippers or buttons, must be removed from the abdominal area to prevent streak artifacts on the images.

During the Procedure

Upon arriving at the imaging department of Lahore PCR Lab, the patient will be greeted by a registered radiologic technologist who will review their medical history, consent forms, and renal function results. The clinical procedure follows a highly structured workflow:

• Intravenous Cannulation: A nurse or technologist will insert a high-flow peripheral intravenous (IV) cannula, typically an 18-gauge or 20-gauge needle, into a large vein in the antecubital fossa of the arm. This large-bore cannula is necessary to withstand the high pressure generated by the automated contrast injector.
• Patient Positioning: The patient is asked to lie supine (on their back) on the motorized CT scanner table. To ensure comfort and stability, pillows and straps may be used. The patient’s arms are positioned above their head to prevent them from causing artifacts on the abdominal images.
• Scout Scan: The table moves slowly through the gantry of the CT scanner to acquire a preliminary “scout” or localizer image. This allows the technologist to precisely plan the scan boundaries, extending from the dome of the diaphragm to the pubic symphysis.
• Contrast Injection and Timing: The IV cannula is connected to a dual-head power injector containing the iodinated contrast agent and a saline flush. The injection is initiated, delivering contrast at a rapid rate of 3.0 to 5.0 mL per second. A saline chaser is injected immediately afterward to compact the contrast bolus and clear the veins.
• Arterial Phase Acquisition: Approximately 25 to 35 seconds after the start of the injection, the scanner automatically triggers the first scan. This late arterial phase captures intense enhancement of the abdominal aorta, hepatic arteries, and hypervascular lesions.
• Portal Venous Phase Acquisition: Approximately 60 to 70 seconds post-injection, the second scan is performed. During this phase, the contrast has circulated through the capillary beds and is draining through the portal vein, providing optimal enhancement of the normal liver parenchyma, portal veins, and hepatic veins.
• Patient Sensation: During the contrast injection, patients commonly experience a warm, flushing sensation throughout their body, a metallic taste in their mouth, and a brief feeling as though they have wet themselves. These are completely normal, transient side effects that resolve within a couple of minutes.
• Breath-Holding Instructions: The scanner will deliver automated voice commands instructing the patient to take a deep breath and hold it for 10 to 15 seconds during each scanning phase. Remaining perfectly still is crucial to eliminate motion artifacts.
• Post-Scan Observation: Once the scans are complete, the IV cannula is removed, and a light dressing is applied. The patient is monitored in a waiting area for approximately 15 to 30 minutes to ensure there are no immediate adverse reactions to the contrast agent.

When is a CT Biphasic with Contrast Performed?

Evaluation of Focal Liver Lesions

Physicians frequently request a CT Biphasic with Contrast scan when an ultrasound or routine blood test reveals an indeterminate mass in the liver. This scan is exceptionally skilled at differentiating between benign lesions, such as hepatic hemangiomas, focal nodular hyperplasia (FNH), or hepatic adenomas, and malignant tumors like hepatocellular carcinoma (HCC) or hypervascular metastases. By analyzing the enhancement kinetics—how quickly the lesion fills with contrast during the arterial phase and washes out during the portal venous phase—radiologists can establish a highly accurate diagnosis without the immediate need for an invasive tissue biopsy.

Staging and Surveillance of Hepatocellular Carcinoma

In patients with chronic liver diseases, such as Hepatitis B, Hepatitis C, or liver cirrhosis, there is a significantly elevated risk of developing hepatocellular carcinoma. Gastroenterologists and hepatologists utilize the biphasic CT protocol as a primary tool for regular surveillance and staging. The scan helps detect early-stage, sub-centimeter tumors that are highly vascular. Accurate staging using this modality determines whether a patient is a candidate for curative treatments, such as surgical resection, liver transplantation, or localized radiofrequency ablation.

Assessment of Pancreatic Neoplasms

The pancreas is a complex organ located deep within the retroperitoneum, making it challenging to evaluate with standard imaging. A biphasic CT scan is highly effective for investigating suspected pancreatic tumors, such as pancreatic ductal adenocarcinoma or pancreatic neuroendocrine tumors (pNETs). Because pancreatic adenocarcinoma is typically hypovascular, it appears as a dark, hypoenhancing mass against the brightly enhancing normal pancreatic parenchyma during the late arterial phase. Conversely, neuroendocrine tumors are hypervascular and show intense enhancement, allowing for clear differentiation and precise localization.

Pre-Surgical and Pre-Transplant Vascular Mapping

Prior to major abdominal surgeries, such as a partial hepatectomy, pancreaticoduodenectomy (Whipple procedure), or living donor liver transplantation, surgeons require a detailed anatomical map of the patient’s blood vessels. A CT Biphasic with Contrast scan provides high-resolution, three-dimensional reconstructions of the hepatic arteries, portal veins, and hepatic veins. This allows the surgical team to identify any anatomical variants, assess for vascular invasion by tumors, and plan the surgical approach with meticulous precision, thereby reducing intraoperative complications.

Investigation of Portal Vein Thrombosis and Portal Hypertension

Patients presenting with signs of portal hypertension, such as ascites, splenomegaly, or esophageal varices, require detailed imaging of the portal venous system. A biphasic CT scan allows for direct visualization of the portal vein during its peak enhancement phase. This is crucial for detecting portal vein thrombosis (blood clots), evaluating the extent of the clot, and identifying collateral venous pathways. It also assists in assessing the patency of surgical shunts or transjugular intrahepatic portosystemic shunts (TIPS).

What Does a CT Biphasic with Contrast Detect?

A CT Biphasic with Contrast scan is capable of detecting a wide array of pathological conditions within the abdominal cavity. Some of the most clinically significant findings include:

• Hepatocellular Carcinoma (HCC): Characterized by intense, chaotic enhancement during the arterial phase followed by rapid “washout” in the portal venous phase.
• Hepatic Hemangioma: A benign vascular tumor showing peripheral, globular, discontinuous enhancement during the arterial phase with progressive centripetal fill-in on later phases.
• Focal Nodular Hyperplasia (FNH): A benign lesion demonstrating rapid, uniform arterial enhancement with a characteristic non-enhancing central scar.
• Hepatic Adenoma: A benign, hypervascular tumor associated with oral contraceptive use, showing arterial enhancement and variable venous phase appearance.
• Hypervascular Liver Metastases: Secondary tumors originating from primary sites such as neuroendocrine tumors, renal cell carcinoma, or thyroid cancer, which light up brightly during the arterial phase.
• Hypovascular Liver Metastases: Secondary tumors, commonly from colorectal or gastric cancers, which appear as hypoenhancing lesions in both phases.
• Portal Vein Thrombosis: A filling defect within the portal vein, indicating a clot that can obstruct blood flow to the liver.
• Hepatic Artery Stenosis: Narrowing of the hepatic artery, often assessed post-liver transplantation to ensure adequate arterial inflow.
• Hepatic Artery Aneurysm: A localized dilation of the hepatic artery that carries a risk of rupture.
• Pancreatic Ductal Adenocarcinoma: A poorly enhancing, infiltrative mass often associated with pancreatic duct dilation and parenchymal atrophy.
• Pancreatic Neuroendocrine Tumors (pNETs): Well-circumscribed, hyperenhancing masses within the pancreatic parenchyma.
• Splenomegaly: Enlargement of the spleen, frequently secondary to portal hypertension or hematological malignancies.
• Splenic Infarction: Wedge-shaped, non-enhancing areas within the splenic parenchyma representing tissue death due to arterial occlusion.
• Liver Cirrhosis: Characterized by a nodular liver surface, hypertrophy of the caudate lobe, atrophy of the right lobe, and widening of the fissures.
• Ascites: Free fluid accumulation within the peritoneal recesses, commonly seen in decompensated liver disease.
• Esophageal and Gastric Varices: Dilated, tortuous collateral veins resulting from portal hypertension.
• Renal Cell Carcinoma (RCC): A hypervascular renal mass showing robust, heterogeneous enhancement during the arterial phase.
• Renal Cysts: Differentiated into simple benign cysts (non-enhancing, fluid attenuation) and complex cysts requiring further evaluation.
• Abdominal Aortic Aneurysm (AAA): Dilation of the abdominal aorta, which can be evaluated for size, thrombus, and risk of rupture.
• Hepatic Abscess: A localized collection of pus, often showing a “cluster sign” or a double-target sign of peripheral enhancement.
• Biliary Obstruction: Dilated intrahepatic or extrahepatic bile ducts secondary to stones, strictures, or tumors.
• Choledocholithiasis: The presence of gallstones within the common bile duct, which may cause biliary stasis and cholangitis.
• Retroperitoneal Lymphadenopathy: Enlarged lymph nodes in the retroperitoneum, indicating metastatic disease, lymphoma, or infection.
• Budd-Chiari Syndrome: Obstruction of hepatic venous outflow, presenting with hepatomegaly, ascites, and poor enhancement of the hepatic veins.
• Adrenal Adenoma: A benign mass in the adrenal gland, characterized by rapid contrast washout on delayed imaging.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that waiting for diagnostic results can be an anxious time for patients and their families. Our imaging department is committed to providing prompt, accurate, and highly detailed reports. Once your CT Biphasic with Contrast scan is completed, the raw volumetric data is processed into multiplanar reconstructions by our advanced imaging workstations.

A consultant radiologist with specialized training in abdominal imaging will meticulously review all phases of your scan, comparing the enhancement patterns and documenting all anatomical findings. The finalized, signed diagnostic report is typically available within 24 to 48 hours of the procedure. Patients can conveniently access their reports and high-resolution digital images online through the secure patient portal of Lahore PCR Lab, or they can collect printed copies and a digital CD directly from our facility in Lahore, Pakistan.

CT Biphasic with Contrast Findings Overview

The following table provides an overview of the anatomical structures evaluated during a CT Biphasic with Contrast scan, contrasting normal appearances with potential abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Liver Parenchyma	Homogeneous attenuation, smooth outer contour, uniform contrast enhancement.	Nodular contour (cirrhosis), focal lesions (HCC, hemangioma, metastases, abscesses).
Hepatic Vasculature	Patent hepatic arteries, portal veins, and hepatic veins with normal caliber.	Portal vein thrombosis, hepatic artery stenosis, Budd-Chiari syndrome, varices.
Pancreas	Normal size, lobulated architecture, uniform enhancement during the pancreatic phase.	Hypoenhancing mass (adenocarcinoma), hyperenhancing lesion (NET), pancreatic duct dilation.
Spleen	Homogeneous enhancement, normal size (less than 12 cm in craniocaudal length).	Splenomegaly, splenic infarcts, lacerations, or focal neoplastic lesions.
Kidneys	Symmetrical size, smooth margins, normal corticomedullary differentiation.	Hypervascular masses (RCC), complex cysts, hydronephrosis, renal calculi.
Biliary Tree	No intrahepatic or extrahepatic biliary ductal dilatation.	Dilated bile ducts, choledocholithiasis, cholangiocarcinoma, gallbladder wall thickening.
Peritoneal Cavity	No free fluid, no abnormal peritoneal thickening or nodularity.	Ascites, peritoneal carcinomatosis, loculated fluid collections, hemoperitoneum.
Lymph Nodes	No pathologically enlarged retroperitoneal or mesenteric lymph nodes (less than 10 mm).	Lymphadenopathy secondary to metastasis, lymphoma, tuberculosis, or reactive changes.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for CT Biphasic with Contrast?

• Experienced Healthcare Professionals: Our team includes highly qualified consultant radiologists and certified radiologic technologists who specialize in advanced abdominal imaging protocols.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication, ensuring a supportive environment throughout the scanning process.
• Quality Diagnostic Services: Lahore PCR Lab utilizes state-of-the-art multi-detector CT scanners capable of acquiring rapid, high-resolution slices for maximum diagnostic clarity.
• Professional Reporting: We deliver comprehensive, detailed diagnostic reports with precise vascular phase analysis to guide your clinical management.
• Modern Diagnostic Approach: Our imaging protocols are continuously updated to align with international radiological standards and guidelines.
• Comfortable Environment: Our facility is designed to minimize patient anxiety, offering a clean, modern, and welcoming atmosphere.
• Convenient Location: Located centrally in Lahore, Pakistan, our diagnostic center is easily accessible for patients from all parts of the city.
• Commitment to Accurate Diagnosis: We maintain strict quality control measures to ensure that every scan meets the highest standards of clinical accuracy.